Pentostatin, Cyclophosphamide and Rituximab (PCR) Regimen

Solimando, Dominic A.; Waddell, J. Aubrey

doi:10.1310/hpj5111-888

Cited by 1 publication

(1 citation statement)

References 33 publications

(134 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The chemotherapy order evaluation guide was completed as a two-page document with an adjunctive or supportive care measures reference table (Figure 3). 13–53 The detailed explanations for each step were formulated and are shown below. Nineteen pharmacists were tested with pre- and post-education simulated chemotherapy orders.…”

Section: Resultsmentioning

confidence: 99%

Creation and evaluation of a cancer chemotherapy order review guide for use at a community hospital

Punke

Waddell

2017

J Oncol Pharm Pract

View full text Add to dashboard Cite

The proper evaluation of cancer chemotherapy orders is necessary for patients to receive safe and effective treatment. The chemotherapy treatment setting is evolving resulting in hospital pharmacists without extensive oncology training or experience now being responsible for evaluation of chemotherapy orders. The primary objective was to create a step-by-step chemotherapy order evaluation guide with a detailed explanation for each step. The secondary objective was to evaluate non-oncology trained pharmacists' ability to accurately review simulated chemotherapy orders post-education using the guide. A two-page chemotherapy order evaluation guide was created based on an accepted method of chemotherapy order review consisting of the following eight steps: regimen verification, clinical trial protocol verification, body surface area calculation, dose calculation, laboratory values, emesis prophylaxis, adjunctive or supportive care measures, and pharmacy labels. A literature search was performed for each step. A detailed explanation for each step was written as a separate component from the guide to encompass the literature search information and current guidelines in a more comprehensive manner. Non-oncology trained community hospital pharmacists were educated on use of the guide for approximately 30 min. The guide was evaluated using timed simulated chemotherapy orders pre- and post-education consisting of a general chemotherapy order and a carboplatin dosing order. Nineteen pharmacists were tested with simulated chemotherapy orders. A significant difference was detected between the pre- and post-education for both the general chemotherapy (p = 0.00032) order and carboplatin dosing order (p = 0.031).

show abstract